ferric citrate

FDA Drug Profile — Auryxia

ferric citrate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Auryxia. Available dosage form: tablet, film coated.

Drug details

Generic Name
ferric citrate
Brand Names
Auryxia
Application Number
NDA205874
Sponsor
Akebia Therapeutics, Inc.
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
TETRAFERRIC TRICITRATE DECAHYDRATE

Indications and Usage

1 INDICATIONS AND USAGE Auryxia is a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. ( 1 ) Auryxia is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis. ( 1 ) 1.1 Hyperphosphatemia in Chronic Kidney Disease on Dialysis Auryxia is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. 1.2 Iron Deficiency Anemia in Chronic Kidney Disease Not on Dialysis Auryxia is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.